The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.


Atalay G., Dirix L., Biganzoli L., Beex L., Nooij M., Cameron D., ...More

Annals of oncology : official journal of the European Society for Medical Oncology, vol.15, pp.211-7, 2004 (SCI-Expanded, Scopus) identifier identifier identifier